Lung Stent Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The lung stent market covers devices including self-expandable metallic stents, silicone stents, and hybrid covered designs used primarily in bronchoscopic and interventional pulmonology procedures. These implants restore and maintain airway patency in patients with malignant airway tumors, inflammatory strictures, tracheal stenosis, and post-intubation complications. The market serves both adult and pediatric populations across hospital, ambulatory surgery center, and specialty pulmonology clinic settings.

• •Market valued at approximately $15.35 billion globally in 2025 with projected compound annual growth of roughly 3.7%
• •Addresses both malignant and benign airway obstruction conditions across diverse patient demographics
• •Encompasses product categories including self-expandable metal stents, silicone stents, and covered stent variants

Rising global incidence of lung cancer and chronic respiratory diseases constitutes the primary demand catalyst, with aging demographics amplifying underlying patient volumes across both developed and emerging healthcare markets. Advancements in minimally invasive bronchoscopic techniques have expanded the treatable patient population by making airway stenting accessible to higher-risk individuals previously considered poor surgical candidates. Favorable reimbursement pathways in major healthcare systems and ongoing clinical evidence generation further support steady procedural adoption rates.

• •Increasing prevalence of lung cancer, COPD, and other chronic airway diseases driving procedural demand
• •Growing adoption of minimally invasive interventional pulmonology expanding addressable patient base
• •Aging global population increasing the at-risk demographic for obstructive airway conditions

The market is segmented by product type into self-expandable metal stents, silicone stents, and covered or hybrid stent variants, with material composition and delivery mechanism serving as key differentiators. Geographically, North America and Europe have historically represented the largest regional markets due to established healthcare infrastructure, higher procedural volumes, and favorable reimbursement environments. Asia-Pacific is emerging as the fastest-growing region, driven by improving access to interventional pulmonology, rising disease burden, and expanding hospital capabilities in countries such as China, India, and Japan.

• •North America leads in market share due to advanced healthcare infrastructure and high adoption of interventional procedures
• •Asia-Pacific projected to witness the fastest growth rate driven by rising disease burden and expanding healthcare access
• •Product segmentation includes self-expandable stents, balloon-expandable stents, and silicone-based designs across material and delivery categories

What are the recent trends and outlook?

The market outlook centers on continued product innovation, including biodegradable stent research, drug-eluting and specialized coated stent variants designed to reduce tissue ingrowth and migration, and improvements in delivery catheter technology enabling more precise placement. Growing emphasis on outpatient and ambulatory setting procedures, combined with expanding training in interventional pulmonology, is expected to broaden the addressable patient base. The cumulative effect of these trends, alongside underlying disease prevalence growth, supports a stable long-term expansion trajectory for the global lung stent market.

• •Ongoing development of biodegradable and bioresorbable stent technologies aimed at reducing long-term complications and eliminating need for removal
• •Rising adoption of covered stents to mitigate tumor in-growth and granulation tissue formation in malignant airway obstructions
• •Expanding interventional pulmonology training programs and outpatient procedure capabilities supporting broader market accessibility